Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluating the efficacy of the ResNet50 deep learning model utilizing thyroid scintigraphy images for predicting the outcomes of initial iodine-131 therapy in patients with Graves’ disease
0
Zitationen
7
Autoren
2025
Jahr
Abstract
This study introduces a pioneering deep learning framework that employs thyroid scintigraphy radiomics to predict iodine-131 therapeutic outcomes in GD. By combining ResNet50 for feature extraction with interpretable Grad-CAM localization, this approach advances personalized nuclear medicine strategies and mitigates the 'black box' limitation typically associated with artificial intelligence models. These findings require validation across multicenter cohorts to refine and optimize precision treatment protocols.
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.077 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.720 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.830 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.349 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.012 Zit.